Hydrogen gas represses the progression of lung cancer via down-regulating CD47.
Jinghong Meng, Leyuan Liu, Dongchang Wang, Zhenfeng Yan, Gang Chen · Bioscience reports · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In the authors' previous study, the authors' project group found that H₂ could decrease the expression of CD47 in lung cancer A549 cells via the next-generation sequencing, indicating that CD47 might be involved in H₂-mediated lung cancer repression. The authors concluded that, the current study reveals that H₂ inhibits the progression of lung cancer via down-regulating CD47, which might be a potent method for lung cancer treatment. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in Up-regulation of CD47 abolished H₂ roles in promoting lung cancer cellular apoptosis and repressing cell growth, invasion and migration in both A549 and H1975 cell lines. In the authors' previous study, the authors' project group found that H₂ could decrease the expression of CD47 in lung cancer A549 cells via the next-generation sequencing, indicating that CD47 might be involved in H₂-mediated lung cancer repression.
What the Researchers Studied
The researchers studied Up-regulation of CD47 abolished H₂ roles in promoting lung cancer cellular apoptosis and repressing cell growth, invasion and migration in both A549 and H1975 cell lines. The study used a in vitro cell-culture laboratory experiment.
What Effects Did Molecular Hydrogen Have?
In the authors' previous study, the authors' project group found that H₂ could decrease the expression of CD47 in lung cancer A549 cells via the next-generation sequencing, indicating that CD47 might be involved in H₂-mediated lung cancer repression. The authors concluded that, the current study reveals that H₂ inhibits the progression of lung cancer via down-regulating CD47, which might be a potent method for lung cancer treatment. Hydrogen gas (H₂) has been identified to play an anti-tumor role in several kinds of cancers, but the molecular mechanisms remain largely unknown.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was Up-regulation of CD47 abolished H₂ roles in promoting lung cancer cellular apoptosis and repressing cell growth, invasion and migration in both A549 and H1975 cell lines. The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.